Delivering vivid and insightful CT images of the coronary vessels directly into the cardiac catheterization laboratories (cath labs) has proven very effective by helping save staff from re-acquiring images of the heart and boosting patient throughput. But CT images are only part of the bigger picture.
February 5, 2008 - Premera Blue Cross has revised its Corporate Medical Policy to make Microvolt T-Wave Alternans ...
Medtronic Inc. received FDA clearance of the Reveal DX Insertable Cardiac Monitor (ICM) designed to help physicians identify the cause of unexplained fainting or abnormal heart rhythms, including ventricular tachyarrhythmias (VT), fast ventricular tachyarrhythmias (FVT), bradyarrhythmias and asystole.
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
February 5, 2008 - The Medical Imaging & Technology Alliance (MITA), a division of NEMA, said today that the budget ...
The Sentinel by Spacelabs reportedly integrates an entire range of noninvasive diagnostic cardiology solutions including ...
Advanced Integrated IVUS Technology
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
A new 320-slice computed tomography (CT) system, the AquilionONE by Toshiba America Medical Systems, delivers dynamic ...
February 5, 2008 - The FAMILION test for Long QT Syndrome (LQTS) has met the Blue Cross and Blue Shield Association ...
February 4, 2008 – Fluke Biomedical unveiled today new defibrillator and pacemaker analyzer technologies, the Impulse 6000D Defibrillator Analyzer and the Impulse 7000DP Defibrillator/Pacer Analyzer, which are designed to be rugged, portable test instrumentation for biomedical technical professionals to ensure proper operation and ultimate performance of critical life-support cardiac resuscitati
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
February 4, 2008 - The Centers for Medicare & Medicaid Services (CMS) announced that after completing a review of its 1986 national non-coverage policy for artificial hearts, its preliminary decision is to provide reimbursement for patients who receive the CardioWest temporary Total Artificial Heart (TAH-t) as part of FDA studies that meet CMS specifications.
Fluke Biomedical's product line of defibrillator and pacemaker analyzer technologies includes the Impulse 6000D ...
February 4, 2008 - InSite One Inc.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
February 1, 2008 - Stentys' bifurcated stent was successfully implanted recently into a 49-year-old male patient at the ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands, marking the sixth successful implantation of the Stentys bifurcated stent platform.
February 1, 2008 - Medtronic Inc. has received approval from the FDA for the Endeavor Zotarolimus-Eluting Coronary Stent ...
January 31, 2008 - Stentys' bifurcated stent was successfully implanted recently into a 49-year-old male patient at the ...
February 04, 2008
